well
recogn
composit
matur
cell
popul
subject
strict
homeostat
control
tcr
repertoir
rel
proport
variou
cell
subset
establish
thymu
continu
shape
regul
peripheri
thymic
function
declin
peripher
homeostat
mechan
assum
increas
import
inde
loss
thymic
function
lead
progress
declin
cell
number
peripher
mechan
ensur
size
cell
popul
maintain
due
prolifer
residu
cell
howev
current
understand
basic
mechan
homeostat
lymphopeniainduc
prolifer
suggest
drive
maintain
popul
size
may
accompani
loss
tcr
divers
emerg
autoreact
effector
cell
predict
support
experiment
clinic
evid
consider
import
lymphopenia
seen
commonli
clinic
practic
consequ
viral
infect
medic
treatment
cancer
autoimmun
graft
reject
lymphopenia
may
simpl
link
viral
infect
autoimmun
may
one
reason
common
failur
potent
nonspecif
immunosuppress
drug
current
clinic
use
success
vertebr
adapt
immun
system
depend
mainten
larg
number
lymphocyt
bear
uniqu
antigen
receptor
enabl
recognit
multitud
unknown
foreign
antigen
addit
immun
system
must
remain
toler
toward
selfantigen
avoid
autoimmun
primari
lymphoid
organ
thymu
bone
marrow
serv
achiev
goal
great
divers
antigen
receptor
result
random
recombin
antigen
receptor
gene
selfreact
lymphocyt
larg
elimin
neg
select
recent
year
also
becom
appreci
composit
size
matur
cell
popul
subject
strict
homeostat
control
peripheri
thu
cell
undergo
prolifer
follow
lymphopeniainduc
insult
absenc
foreign
antigen
stimul
enabl
cell
restor
size
peripher
popul
absenc
thymu
inde
lymphopeniainduc
prolifer
lip
shown
import
fig
schemat
represent
immun
reconstitut
follow
lymphopeniainduc
insult
cell
shown
uniqu
symbol
repres
uniqu
tcr
mani
cell
lost
follow
insult
presenc
function
thymu
full
tcr
divers
restor
howev
absenc
function
thymu
cell
popul
size
restor
via
lip
maxim
possibl
divers
maintain
ideal
situat
cell
prolifer
equal
contrast
tcr
divers
decreas
oligoclon
expans
potenti
autoreact
cell
situat
cell
select
advantag
immun
reconstitut
physiolog
mechan
initi
popul
peripher
cell
compart
murin
neonat
lymphopen
state
also
rel
common
occurr
throughout
life
lip
may
primari
physiolog
mean
cell
popul
recoveri
age
individu
fail
thymic
function
although
mechan
regul
lip
still
defin
becom
appar
prolif
capac
individu
cell
correl
avid
selfligand
lip
potenti
skew
tcr
repertoir
toward
greater
selfreact
fig
addit
normal
peripher
toler
mechan
may
fail
lymphopen
state
cell
acquir
effector
function
cours
lip
factor
may
explain
longrecogn
paradox
associ
lymphopenia
autoimmun
fact
consid
commonli
lymphopenia
may
occur
within
lifetim
individu
reason
consid
autoimmun
common
mechan
may
promot
tcr
divers
mainten
toler
lymphopen
state
consider
may
signific
implic
clinic
protocol
result
cell
deplet
use
organ
transplant
treatment
autoimmun
two
broad
categori
forc
control
cell
homeostasi
stimulatori
inhibitori
factor
although
cell
appear
quiescent
steadi
state
condit
constant
competit
space
determin
access
control
factor
individu
clone
prolifer
die
replac
new
migrant
thymu
rate
gener
balanc
lymphopen
state
cell
may
driven
prolifer
due
excess
stimulatori
defici
inhibitori
factor
bestestablish
posit
factor
includ
signal
selfpeptidemhc
complex
certain
cytokin
known
play
essenti
domin
role
cell
homeostasi
sever
cytokin
chemokin
eg
provid
addit
posit
signal
costimulatori
signal
also
play
posit
role
least
cell
less
known
potenti
inhibitori
factor
although
regulatori
cell
potenti
restrain
lip
although
cell
clone
may
least
first
glanc
equal
access
variou
cytokin
resourc
clearli
differ
avid
selfpeptidemhc
complex
inde
cell
higher
avid
selfligand
greater
potenti
undergo
lip
thu
quit
plausibl
lip
may
alter
tcr
repertoir
toward
greater
selfreact
cours
review
also
consid
mechan
may
preferenti
restrain
expans
autoreact
clone
provid
protect
autoimmun
diseas
discuss
import
consid
variou
lymphopen
model
clinic
state
may
fundament
differ
one
anoth
gener
systemat
compar
thu
ragdefici
scid
individu
absolut
defici
regulatori
cell
unlik
cytokin
produc
innat
immun
element
stromal
cell
would
repres
limit
resourc
inoculum
transfer
cell
contrast
irradi
chemotherapi
may
neg
impact
product
homeostat
cytokin
normal
regul
steadi
state
b
lead
widespread
apoptosi
releas
addit
cytokin
proinflammatori
andor
immunosuppress
c
leav
residu
popul
competitor
cell
differenti
affect
regulatori
cell
subset
similar
addit
consider
may
appli
lymphopeniainduc
variou
viral
infect
qualiti
limit
posit
neg
factor
associ
differ
model
clinic
state
may
greatli
affect
cours
lip
composit
recov
cell
popul
potenti
autoimmun
well
document
steadi
state
condit
vivo
cell
receiv
constant
stimul
selfpeptidemhc
molecul
respons
partial
tyrosin
phosphoryl
tcrassoci
cell
import
continu
lowlevel
peripher
cell
stimul
selfligand
recent
begun
appreci
propos
prevent
autoreact
increas
tone
neg
regulatori
element
within
cell
signal
apparatu
also
shown
engag
selfpeptidemhc
complex
facilit
cell
sensit
toward
foreign
peptidemhc
complex
final
selfpeptidemhcinduc
signal
propos
critic
homeostasi
cell
selfpeptidemhcinduc
signal
propos
mani
group
play
import
role
cell
surviv
two
major
type
experi
use
test
idea
adopt
transfer
mhcdefici
host
genet
ablat
tcr
express
one
difficulti
adopt
transfer
studi
yield
wide
vari
result
nkmediat
reject
donor
popul
proven
problem
mhc
class
idefici
recipi
also
problem
studi
mhc
class
iidefici
mice
despit
extens
backcross
still
carri
nk
target
differ
origin
mutant
mice
gener
embryon
stem
cell
addit
mani
earlier
studi
use
lymphopen
recipi
mice
made
difficult
separ
effect
mhc
signal
cell
surviv
versu
lip
nevertheless
tcr
ablat
studi
also
suggest
least
surviv
advantag
cell
receiv
baselin
tcr
stimul
howev
argu
tcrdefici
cell
may
decreas
signal
via
andor
molecul
may
also
contribut
cell
surviv
gener
cell
note
significantli
sensit
condit
tcr
ablat
term
surviv
cell
fact
surviv
cell
may
entir
independ
tonic
mhc
signal
howev
remain
possibl
signal
may
provid
surviv
advantag
individu
cell
condit
competit
space
exist
steadi
state
studi
track
bulk
number
individu
tcr
transgen
polyclon
popul
although
evid
surviv
signal
provid
selfpeptidemhc
complex
remain
controversi
gener
agreement
signal
critic
lip
great
differ
individu
abil
variou
tcr
transgen
cell
undergo
lip
larg
explain
differenti
avid
selfpeptidemhc
complex
similarli
polyclon
cell
popul
character
higher
express
level
correl
higher
level
basal
tcr
stimul
prolifer
vigor
lymphopen
condit
low
popul
fact
signal
selfpeptidemhc
complex
may
constitut
limit
resourc
cell
undergo
lip
provid
select
advantag
cell
greatest
affin
selfpeptidemhc
complex
convers
number
abund
distinct
selfligand
peripheri
current
known
principl
set
absolut
minimum
level
tcr
divers
popul
gener
cours
lip
well
recogn
costimulatori
molecul
provid
signal
critic
outcom
normal
antigenspecif
respons
howev
role
costimul
homeostasi
cell
yet
extens
studi
among
mani
costimulatori
molecul
role
far
receiv
attent
mutant
mice
defici
express
normal
lymphoid
cellular
show
subtl
chang
within
cell
compart
eg
greater
ratio
cell
compar
wildtyp
mice
interestingli
number
regulatori
cell
markedli
reduc
anim
probabl
compens
immun
defici
expect
loss
costimul
other
recent
shown
costimulatori
signal
play
signific
role
lip
although
cell
rate
lip
substanti
diminish
absenc
signal
defect
becom
consider
appar
mix
wildtyp
popul
allow
compet
follow
cotransf
lymphopen
hoststh
wildtyp
cell
becom
domin
interestingli
absenc
costimul
preferenti
restrain
vigor
divid
cell
littl
effect
cell
undergo
cell
divis
result
suggest
cours
lip
costimulatori
signal
may
especi
benefit
cell
receiv
selfligand
stimul
may
amplifi
select
favor
selfreact
tcr
repertoir
discuss
regul
aspect
immun
system
longer
complet
without
consider
potenti
function
regulatori
cell
although
multipl
type
regulatori
cell
identifi
recent
year
major
investig
far
focus
cell
fraction
character
constitut
express
cell
play
critic
role
mainten
selftoler
cell
appear
receiv
greater
degre
constitut
stimul
peripher
selfantigen
cell
requir
express
member
forkheadwing
helix
famili
transcript
regul
develop
function
interest
note
model
autoimmun
use
demonstr
suppress
function
cell
involv
lymphopen
mice
thu
formal
possibl
cell
play
central
role
regul
size
composit
cell
compart
inde
mice
lack
function
express
thu
lack
regulatori
cell
develop
fatal
lymphoprolif
autoimmun
similar
pattern
autoimmun
seen
human
immun
dysregul
polyendocrinopathi
enteropathi
xlink
syndrom
ipex
result
mutat
nevertheless
contribut
regulatori
cell
control
cell
homeostasi
remain
controversi
mere
deplet
cell
induc
cell
prolifer
trigger
autoimmun
howev
cell
limit
peripher
expans
polyclon
cell
associ
develop
inflammatori
bowel
diseas
follow
transfer
ragdefici
mice
addit
shown
cell
restrain
lymphopeniainduc
prolifer
tcr
transgen
cell
respond
known
selfantigen
compon
enter
flora
caus
diseas
interestingli
similar
pattern
observ
blockad
cell
preferenti
restrain
vigor
divid
cell
littl
effect
initi
sever
cell
divis
import
note
cell
undergo
mani
cell
divis
cours
lymphopeniainduc
prolifer
acquir
phenotyp
function
characterist
virtual
indistinguish
effectormemori
cell
produc
effector
cytokin
becom
independ
costimul
antigen
activ
alter
express
surfac
marker
commonli
use
distinguish
memori
cell
eg
acquir
abil
migrat
peripher
tissu
addit
recent
evid
suggest
cell
acquir
memoryeffector
phenotyp
cours
lip
becom
resist
toler
induct
convent
protocol
exampl
antigen
exposur
accompani
costimulatori
blockad
recent
data
tcr
transgen
cell
adopt
transfer
experi
suggest
administr
system
cognat
antigen
tolerogen
form
lead
partial
delet
function
inactiv
antigenspecif
cell
normal
anim
fail
render
unrespons
lymphopen
host
caus
dramat
clonal
expans
lip
lead
preferenti
expans
autoreact
cell
clone
failur
normal
toler
mechan
signific
leap
imagin
would
also
lead
develop
autoimmun
diseas
fact
multipl
anim
model
support
idea
interestingli
regulatori
cell
proven
central
import
control
autoimmun
phenomena
model
one
earliest
exampl
autoimmun
affect
multipl
organ
eg
stomach
thyroid
pancreat
islet
adren
gland
gonad
follow
thymectomi
day
birth
mice
similar
autoimmun
follow
thymectomi
subleth
irradi
rat
suspect
earli
neonat
thymectomi
result
preferenti
elimin
suppressor
cell
eventu
sakaguchi
et
al
defin
subset
constitut
express
demonstr
pattern
organspecif
autoimmun
follow
neonat
thymectomi
could
reproduc
adopt
transfer
splenic
cell
suspens
athym
nude
mice
autoimmun
prevent
cotransf
cell
interestingli
fatal
inflammatori
bowel
diseas
lung
inflamm
rather
polyglandular
autoimmun
domin
clinic
pictur
scid
rag
mice
receiv
polyclon
cell
diseas
also
suppress
cell
might
predict
neonat
thymectomi
associ
restrict
tcr
repertoir
oligoclon
expans
inde
mice
normal
lymphopen
initi
week
birth
even
presenc
thymu
depend
lip
fill
cell
compart
thymectomi
perform
day
birth
elimin
sourc
new
cell
could
diversifi
tcr
repertoir
specif
prevent
develop
regulatori
cell
interest
note
essenti
featur
neonat
thymectomi
model
autoimmun
reproduc
neonat
infect
mous
lymphotrop
viru
mtlv
viru
caus
transient
select
deplet
cell
thymu
peripheri
directli
infect
organ
later
target
autoimmun
respons
similarli
neonat
thymectomi
model
time
infect
appear
critic
administr
mtlv
day
caus
autoimmun
furthermor
regulatori
cell
appear
preferenti
affect
neonat
mtlv
infect
autoimmun
prevent
adopt
transfer
cell
adopt
transfer
model
recapitul
role
lymphopenia
regulatori
cell
diseas
pathogenesi
inflammatori
bowel
diseas
scid
rag
recipi
driven
cell
specif
enter
flora
antigen
undergo
select
hyperexpans
howev
clinic
immunopatholog
develop
follow
establish
critic
number
pathogen
cell
thu
size
cell
inoculum
import
variabl
pathogenesi
diseas
modela
larg
inoculum
limit
lymphopenia
consequ
limit
number
pathogen
cell
clone
emerg
cours
lip
sever
anim
model
spontan
autoimmun
link
lymphopenia
among
nonobes
diabet
nod
mous
like
model
multipl
describ
immun
defect
provid
interest
case
studi
discuss
lymphoid
tissu
nod
mice
contain
fewer
cell
addit
although
regulatori
cell
mice
function
present
smaller
number
seen
mous
strain
shown
nod
mice
overexpress
drive
rapid
prolifer
least
subset
cell
provid
surviv
signal
therefor
cell
nod
mice
may
experi
continu
pressur
undergo
lip
allow
expans
unstabl
popul
autodestruct
cell
lymphopenia
long
associ
varieti
human
autoimmun
diseas
exampl
lymphopenia
diagnos
mostli
peripher
blood
sampl
includ
sjogren
diseas
rheumatoid
arthriti
system
lupu
erythematosu
polymyos
dermatomys
celiac
diseas
crohn
diseas
addit
diseas
associ
poor
splenic
function
celiac
diseas
particular
well
document
commonli
accompani
splenic
gener
lymphoid
atrophi
depth
analysi
cell
popul
rheumatoid
arthriti
patient
reveal
number
featur
consist
poor
thymic
function
enhanc
activ
lip
activ
includ
decreas
proport
newli
gener
thymic
immigr
contract
tcr
divers
oligoclon
cell
expans
specul
transient
lymphopeniainduc
viral
infect
might
nonspecif
trigger
autoimmun
inde
lymphopenia
commonli
associ
mani
viral
infect
eg
influenza
measl
rubella
parvoviru
west
nile
enceph
viru
sever
acut
respiratori
syndrom
sar
viru
other
infect
virus
specif
causal
link
autoimmun
arguabl
viru
recogn
lymphopenia
human
immunodefici
viru
hiv
caus
profound
progress
deplet
cell
inde
acquir
immunodefici
syndrom
aid
associ
autoimmun
furthermor
autoimmun
increasingli
recogn
trigger
signific
number
aid
patient
highli
activ
antiretrovir
therapi
haart
allow
reconstitut
cell
compart
interestingli
hiv
may
preferenti
target
cell
howev
regulatori
cell
mani
hivspecif
also
preferenti
expand
patient
treat
haart
may
protect
autoimmun
might
otherwis
sever
present
higher
incid
noteworthi
immun
reconstitut
proce
variabl
treat
aid
patient
differ
mechanist
factor
may
explain
rang
respons
haart
suscept
haarttrigg
autoimmun
still
need
defin
induct
lymphopenia
common
medic
practic
obviou
exampl
includ
radiat
chemotherapi
cancer
cell
deplet
antibodi
immunosuppress
medic
lack
increas
report
incid
autoimmun
among
cancer
survivor
suggest
transient
lymphopenia
caus
irradi
chemotherapi
alon
insuffici
autoimmun
diseas
induct
altern
exist
associ
yet
made
subtl
sign
autoimmun
eg
autoantibodi
may
simpli
yet
recogn
addit
note
earlier
major
differ
may
exist
irradi
andor
chemotherapyinduc
lymphopen
state
versu
induc
viral
infect
genet
immunodefici
nevertheless
shown
experiment
subleth
irradi
potenti
antitumor
immun
respons
transfus
autolog
syngen
cell
undergo
homeostat
prolifer
similarli
cytotox
chemotherapi
impair
toler
tumorspecif
effector
cell
enhanc
potenc
immunotherapi
direct
solid
tumor
potent
immunosuppress
drug
current
use
treat
autoimmun
prevent
reject
potenti
caus
lymphopenia
true
exampl
cyclosporin
csa
corticosteroid
caus
thymic
involut
delet
doubleposit
thymocyt
peripher
lymphopenia
interest
observ
experiment
autoimmun
induc
treat
anim
irradi
csa
follow
csa
withdraw
multipl
mechan
may
play
role
diseas
eg
abrog
central
peripher
toler
possibl
lymphopeniainduc
autoimmun
may
also
play
role
human
condit
eg
inflammatori
bowel
diseas
corticosteroid
effect
control
acut
diseas
exacerb
fail
prophylact
agent
continu
use
inde
possibl
summat
lymphopen
insult
induc
intermitt
corticosteroid
use
lead
acceler
underli
autoimmun
diseas
long
run
notabl
increasingli
potent
cell
deplet
drug
introduc
clinic
one
exampl
monoclon
antibodi
caus
profound
prolong
deplet
cell
hematopoiet
cell
seem
paradox
drug
alreadi
prove
pose
risk
trigger
autoimmun
thu
third
patient
receiv
intent
treat
multipl
sclerosi
develop
autoimmun
hyperthyroid
organ
transplant
one
clinic
situat
lymphopenia
induc
deliber
noteworthi
set
larg
precursor
frequenc
graftspecif
cell
among
residu
host
cell
larg
precursor
frequenc
hostspecif
cell
among
graft
inde
graftversushost
diseas
rule
rather
except
bone
marrow
transplant
induct
lymphopenia
mandatori
furthermor
attempt
minim
acut
reject
decreas
burden
longterm
immunosuppress
cell
deplet
becom
increasingli
common
immunosuppress
strategi
time
solid
organ
implant
howev
possibl
iatrogen
lymhopenia
may
actual
play
causal
role
chronic
reject
may
exacerb
acut
reject
patient
discontinu
chronic
immunosuppress
medic
respect
note
despit
promis
potent
celldeplet
drug
abl
prevent
graft
reject
preliminari
studi
longerterm
outcom
still
pend
ultim
goal
transplant
immunologist
induct
graftspecif
toler
rather
gener
immunosuppress
inde
increas
understand
cell
activ
costimulatori
requir
alreadi
yield
multipl
promis
experiment
approach
aim
achiev
goal
howev
induct
lymphopenia
may
abrog
graftspecif
toler
induct
acceler
graft
reject
research
understand
immunolog
toler
past
decad
primarili
focus
phenotyp
individu
lymphocyt
biochem
mechan
underli
cell
anergi
suppress
mechan
immunosuppress
drug
gener
understood
term
effect
intracellular
signal
pathway
howev
understand
immunolog
toler
incomplet
without
appreci
adapt
immun
respons
mediat
popul
lymphocyt
cell
popul
complex
character
term
divers
tcr
repertoir
abund
selfreact
clone
proport
regulatori
vari
phenotyp
effector
memori
cell
composit
cell
compart
mani
subcompart
subject
strict
homeostat
control
mechan
major
disrupt
cell
homeostasi
known
result
infect
medic
intervent
gener
thought
repres
mere
transient
phenomena
fact
result
perman
chang
composit
cell
compart
popul
level
compromis
protect
capabl
immun
system
augment
potenti
caus
autoimmun
increas
understand
mechan
regul
cell
homeostasi
may
improv
current
strategi
restrain
unwant
augment
desir
immun
respons
among
strategi
optim
divers
tcr
repertoir
mainten
selftoler
may
protect
regulatori
cell
popul
costimulatori
blockad
like
near
futur
gener
immunosuppress
deliber
cell
deplet
retir
riski
rel
ineffect
longterm
treatment
next
gener
immunosuppress
strategi
treatment
transplant
reject
autoimmun
aim
optim
divers
tcr
repertoir
preserv
perhap
enhanc
function
regulatori
cell
target
cell
deplet
unwant
antigenspecif
subpopul
convers
understand
mechan
regul
cell
homeostasi
improv
attempt
achiev
preferenti
expans
effector
function
antitumor
specif
cell
